Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

57.25
Delayed Data
As of May 25
 +1.60 / +2.88%
Today’s Change
33.30
Today|||52-Week Range
59.05
+43.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues75.8M80.4M88.4M90.4M
 
 
 
 
 
Cost of Goods Sold2.6M2.1M2.5M1.6M
 
 
 
 
 
Depreciation And Amortization1.3M4.4M1.7M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income72.0M74.0M84.3M87.2M
 
 
 
 
 
General Expenses45.9M51.6M49.9M55.8M
 
 
 
 
 
Research And Development10.8M13.0M16.2M18.9M
 
 
 
 
 
Total Operating Expenses49.8M58.1M54.1M59.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income26.1M22.3M34.3M31.4M
 
 
 
 
 
Extraordinary Credit23.0K0.000.000.00
 
 
Extraordinary Charge-103.0K-91.0K0.000.00
 
 
 
Interest Expense On Debt218.0K155.0K160.0K1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income26.4M22.9M35.1M31.2M
 
 
 
 
 
Income Taxes-9.1M-6.9M-21.4M-4.8M
 
 
 
 
 
Net Income17.4M16.0M13.7M26.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.5M51.0M51.3M51.5M
 
 
 
 
 
Shares To Calculate EPS Diluted53.2M53.6M53.5M53.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.32$0.29$0.26$0.49
 
 
 
 
 
EPS Diluted$0.32$0.29$0.26$0.49